SCAVONE, CRISTINA
SCAVONE, CRISTINA
Dipartimento di Scienze della Vita, della Salute e delle Professioni Sanitarie
Amelioration of diastolic dysfunction by dapagliflozin in a non-diabetic model involves coronary endothelium
2020-01-01 Cappetta, D.; De Angelis, A.; Ciuffreda, L. P.; Coppini, R.; Cozzolino, A.; Micciche, A.; Dell'Aversana, C.; D'Amario, D.; Cianflone, E.; Scavone, C.; Santini, L.; Palandri, C.; Naviglio, S.; Crea, F.; Rota, M.; Altucci, L.; Rossi, F.; Capuano, A.; Urbanek, K.; Berrino, L.
Angiotensin II and angiotensin 1–7: which is their role in atrial fibrillation?
2020-01-01 Mascolo, Annamaria; Urbanek, Konrad; De Angelis, Antonella; Sessa, Maurizio; Scavone, Cristina; Berrino, Liberato; Rosano, Giuseppe Massimo Claudio; Capuano, Annalisa; Rossi, Francesco
Anti-hypertensive drugs deprescribing: an updated systematic review of clinical trials
2021-01-01 Crisafulli, S.; Luxi, N.; Coppini, R.; Capuano, A.; Scavone, C.; Zinzi, A.; Vecchi, S.; Onder, G.; Sultana, J.; Trifiro, G.
Cardiac Events Potentially Associated to Remdesivir: An Analysis from the European Spontaneous Adverse Event Reporting System
2021-01-01 Rafaniello, Concetta; Ferrajolo, Carmen; Sullo, Maria Giuseppa; Gaio, Mario; Zinzi, Alessia; Scavone, Cristina; Gargano, Francesca; Coscioni, Enrico; Rossi, Francesco; Capuano, Annalisa
Correction to: Angiotensin II and angiotensin 1–7: which is their role in atrial fibrillation?
2020-01-01 Mascolo, Annamaria; Urbanek, Konrad; De Angelis, Antonella; Sessa, Maurizio; Scavone, Cristina; Berrino, Liberato; Rosano, Giuseppe Massimo Claudio; Capuano, Annalisa; Rossi, Francesco
Current pharmacological treatments for COVID-19: What's next?
2020-01-01 Scavone, Cristina; Brusco, Simona; Bertini, Michele; Sportiello, Liberata; Rafaniello, Concetta; Zoccoli, Alice; Berrino, Liberato; Racagni, Giorgio; Rossi, Francesco; Capuano, Annalisa
Drugs-induced pathological gambling: An analysis of italian spontaneous reporting system
2019-01-01 Scavone, Cristina; Stelitano, Barbara; Rafaniello, Concetta; Rossi, Francesco; Sportiello, Liberata; Capuano, Annalisa
Hypernatremia During Intravenous Treatment With Fosfomycin: A Retrospective Medical Record Review Study and an Analysis of Spontaneous Reports in the EudraVigilance Database
2022-01-01 Scavone, Cristina; Mascolo, Annamaria; Bernardi, Francesca Futura; Aiezza, Maria Luisa; Saturnino, Paola; Morra, Gaia; Simonelli, Margherita; Massa, Marida; Pomicino, Andrea; Minei, Giuseppina; Pisapia, Raffaella; Spatarella, Micaela; Trama, Ugo; Guglielmi, Gaspare; Capuano, Annalisa; Perrella, Alessandro
Immune Checkpoint Inhibitors and Scleroderma: Data from the European Pharmacovigilance Database
2024-01-01 Nicoletti, M. M.; Crisci, E.; Cosenza, V.; Riccardi, C.; Campitiello, M. R.; Ruggiero, D.; Berrino, P. M.; Docimo, G.; Scavone, C.
Neurological Manifestations Related to Immune Checkpoint Inhibitors: Reverse Translational Research by Using the European Real-World Safety Data
2022-01-01 Ruggiero, Rosanna; Stelitano, Barbara; Fraenza, Federica; di Mauro, Gabriella; Scavone, Cristina; Sportiello, Liberata; Rafaniello, Concetta; Di Napoli, Raffaella; Danesi, Romano; Del Re, Marzia; Rossi, Francesco; Capuano, Annalisa
Pregnancy Recommendations Solely Based on Preclinical Evidence Should Be Integrated with Real-World Evidence: A Disproportionality Analysis of Certolizumab and Other TNF-Alpha Inhibitors Used in Pregnant Patients with Psoriasis
2024-01-01 Gaio, M.; Vastarella, M. G.; Sullo, M. G.; Scavone, C.; Riccardi, C.; Campitiello, M. R.; Sportiello, L.; Rafaniello, C.
Quinolones-Induced Musculoskeletal, Neurological, and Psychiatric ADRs: A Pharmacovigilance Study Based on Data From the Italian Spontaneous Reporting System
2020-01-01 Scavone, C; Mascolo, A; Ruggiero, R; Sportiello, L; Rafaniello, C; Berrino, L; Capuano, A
Response to the comment on “SGLT-2 inhibitors reduce the risk of cerebrovascular/cardiovascular outcomes and mortality: A systematic review and meta-analysis of retrospective cohort studies”
2021-01-01 Mascolo, A.; Scavone, C.; Scisciola, L.; Chiodini, P.; Capuano, A.; Paolisso, G.
Response to the comment “Is SGLT2i superior to DPP4i for primary and secondary prevention of cardiovascular diseases and death in patients with type 2 diabetes?”
2021-01-01 Mascolo, A.; Scavone, C.; Scisciola, L.; Chiodini, P.; Capuano, A.; Paolisso, G.
Safety of Anticancer Agents Used in Children: A Focus on Their Off-Label Use Through Data From the Spontaneous Reporting System
2020-01-01 Mascolo, A; Scavone, C; Bertini, M; Brusco, S; Punzo, F; Pota, E; Di Martino, M; Di Pinto, D; Rossi, F
SARS-Cov-2 infection: Response of human immune system and possible implications for the rapid test and treatment
2020-01-01 di Mauro, Gabriella; Scavone, Cristina; Rafaniello, Concetta; Rossi, Francesco; Capuano, Annalisa
Severe Cutaneous Adverse Drug Reactions Associated with Allopurinol: An Analysis of Spontaneous Reporting System in Southern Italy
2020-01-01 Scavone, C; Di Mauro, C; Ruggiero, R; Bernardi, Ff; Trama, U; Aiezza, Ml; Rafaniello, C; Capuano, A
SGLT-2 inhibitors reduce the risk of cerebrovascular/cardiovascular outcomes and mortality: A systematic review and meta-analysis of retrospective cohort studies
2021-01-01 Mascolo, A.; Scavone, C.; Scisciola, L.; Chiodini, P.; Capuano, A.; Paolisso, G.
T-cell malignancies following CAR T-Cell therapy: insights from the FDA Adverse Event Reporting System (FAERS)
2024-01-01 Di Napoli, R.; Balzano, N.; Ruggiero, R.; Mascolo, A.; Scavone, C.; di Mauro, G.; Capuano, A.
The Safety Profile of COVID-19 Vaccines in Patients Diagnosed with Multiple Sclerosis: A Retrospective Observational Study
2022-01-01 Maniscalco, Giorgia Teresa; Scavone, Cristina; Mascolo, Annamaria; Manzo, Valentino; Prestipino, Elio; Guglielmi, Gaspare; Aiezza, Maria Luisa; Cozzolino, Santolo; Bracco, Adele; Moreggia, Ornella; Di Giulio Cesare, Daniele; Ziello, Antonio Rosario; Falco, Angela; Massa, Marida; Majolo, Massimo; Raiola, Eliana; Soprano, Roberto; Russo, Giuseppe; Longo, Giuseppe; Andreone, Vincenzo; Capuano, Annalisa
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Amelioration of diastolic dysfunction by dapagliflozin in a non-diabetic model involves coronary endothelium | 1-gen-2020 | Cappetta, D.; De Angelis, A.; Ciuffreda, L. P.; Coppini, R.; Cozzolino, A.; Micciche, A.; Dell'Aversana, C.; D'Amario, D.; Cianflone, E.; Scavone, C.; Santini, L.; Palandri, C.; Naviglio, S.; Crea, F.; Rota, M.; Altucci, L.; Rossi, F.; Capuano, A.; Urbanek, K.; Berrino, L. | |
Angiotensin II and angiotensin 1–7: which is their role in atrial fibrillation? | 1-gen-2020 | Mascolo, Annamaria; Urbanek, Konrad; De Angelis, Antonella; Sessa, Maurizio; Scavone, Cristina; Berrino, Liberato; Rosano, Giuseppe Massimo Claudio; Capuano, Annalisa; Rossi, Francesco | |
Anti-hypertensive drugs deprescribing: an updated systematic review of clinical trials | 1-gen-2021 | Crisafulli, S.; Luxi, N.; Coppini, R.; Capuano, A.; Scavone, C.; Zinzi, A.; Vecchi, S.; Onder, G.; Sultana, J.; Trifiro, G. | |
Cardiac Events Potentially Associated to Remdesivir: An Analysis from the European Spontaneous Adverse Event Reporting System | 1-gen-2021 | Rafaniello, Concetta; Ferrajolo, Carmen; Sullo, Maria Giuseppa; Gaio, Mario; Zinzi, Alessia; Scavone, Cristina; Gargano, Francesca; Coscioni, Enrico; Rossi, Francesco; Capuano, Annalisa | |
Correction to: Angiotensin II and angiotensin 1–7: which is their role in atrial fibrillation? | 1-gen-2020 | Mascolo, Annamaria; Urbanek, Konrad; De Angelis, Antonella; Sessa, Maurizio; Scavone, Cristina; Berrino, Liberato; Rosano, Giuseppe Massimo Claudio; Capuano, Annalisa; Rossi, Francesco | |
Current pharmacological treatments for COVID-19: What's next? | 1-gen-2020 | Scavone, Cristina; Brusco, Simona; Bertini, Michele; Sportiello, Liberata; Rafaniello, Concetta; Zoccoli, Alice; Berrino, Liberato; Racagni, Giorgio; Rossi, Francesco; Capuano, Annalisa | |
Drugs-induced pathological gambling: An analysis of italian spontaneous reporting system | 1-gen-2019 | Scavone, Cristina; Stelitano, Barbara; Rafaniello, Concetta; Rossi, Francesco; Sportiello, Liberata; Capuano, Annalisa | |
Hypernatremia During Intravenous Treatment With Fosfomycin: A Retrospective Medical Record Review Study and an Analysis of Spontaneous Reports in the EudraVigilance Database | 1-gen-2022 | Scavone, Cristina; Mascolo, Annamaria; Bernardi, Francesca Futura; Aiezza, Maria Luisa; Saturnino, Paola; Morra, Gaia; Simonelli, Margherita; Massa, Marida; Pomicino, Andrea; Minei, Giuseppina; Pisapia, Raffaella; Spatarella, Micaela; Trama, Ugo; Guglielmi, Gaspare; Capuano, Annalisa; Perrella, Alessandro | |
Immune Checkpoint Inhibitors and Scleroderma: Data from the European Pharmacovigilance Database | 1-gen-2024 | Nicoletti, M. M.; Crisci, E.; Cosenza, V.; Riccardi, C.; Campitiello, M. R.; Ruggiero, D.; Berrino, P. M.; Docimo, G.; Scavone, C. | |
Neurological Manifestations Related to Immune Checkpoint Inhibitors: Reverse Translational Research by Using the European Real-World Safety Data | 1-gen-2022 | Ruggiero, Rosanna; Stelitano, Barbara; Fraenza, Federica; di Mauro, Gabriella; Scavone, Cristina; Sportiello, Liberata; Rafaniello, Concetta; Di Napoli, Raffaella; Danesi, Romano; Del Re, Marzia; Rossi, Francesco; Capuano, Annalisa | |
Pregnancy Recommendations Solely Based on Preclinical Evidence Should Be Integrated with Real-World Evidence: A Disproportionality Analysis of Certolizumab and Other TNF-Alpha Inhibitors Used in Pregnant Patients with Psoriasis | 1-gen-2024 | Gaio, M.; Vastarella, M. G.; Sullo, M. G.; Scavone, C.; Riccardi, C.; Campitiello, M. R.; Sportiello, L.; Rafaniello, C. | |
Quinolones-Induced Musculoskeletal, Neurological, and Psychiatric ADRs: A Pharmacovigilance Study Based on Data From the Italian Spontaneous Reporting System | 1-gen-2020 | Scavone, C; Mascolo, A; Ruggiero, R; Sportiello, L; Rafaniello, C; Berrino, L; Capuano, A | |
Response to the comment on “SGLT-2 inhibitors reduce the risk of cerebrovascular/cardiovascular outcomes and mortality: A systematic review and meta-analysis of retrospective cohort studies” | 1-gen-2021 | Mascolo, A.; Scavone, C.; Scisciola, L.; Chiodini, P.; Capuano, A.; Paolisso, G. | |
Response to the comment “Is SGLT2i superior to DPP4i for primary and secondary prevention of cardiovascular diseases and death in patients with type 2 diabetes?” | 1-gen-2021 | Mascolo, A.; Scavone, C.; Scisciola, L.; Chiodini, P.; Capuano, A.; Paolisso, G. | |
Safety of Anticancer Agents Used in Children: A Focus on Their Off-Label Use Through Data From the Spontaneous Reporting System | 1-gen-2020 | Mascolo, A; Scavone, C; Bertini, M; Brusco, S; Punzo, F; Pota, E; Di Martino, M; Di Pinto, D; Rossi, F | |
SARS-Cov-2 infection: Response of human immune system and possible implications for the rapid test and treatment | 1-gen-2020 | di Mauro, Gabriella; Scavone, Cristina; Rafaniello, Concetta; Rossi, Francesco; Capuano, Annalisa | |
Severe Cutaneous Adverse Drug Reactions Associated with Allopurinol: An Analysis of Spontaneous Reporting System in Southern Italy | 1-gen-2020 | Scavone, C; Di Mauro, C; Ruggiero, R; Bernardi, Ff; Trama, U; Aiezza, Ml; Rafaniello, C; Capuano, A | |
SGLT-2 inhibitors reduce the risk of cerebrovascular/cardiovascular outcomes and mortality: A systematic review and meta-analysis of retrospective cohort studies | 1-gen-2021 | Mascolo, A.; Scavone, C.; Scisciola, L.; Chiodini, P.; Capuano, A.; Paolisso, G. | |
T-cell malignancies following CAR T-Cell therapy: insights from the FDA Adverse Event Reporting System (FAERS) | 1-gen-2024 | Di Napoli, R.; Balzano, N.; Ruggiero, R.; Mascolo, A.; Scavone, C.; di Mauro, G.; Capuano, A. | |
The Safety Profile of COVID-19 Vaccines in Patients Diagnosed with Multiple Sclerosis: A Retrospective Observational Study | 1-gen-2022 | Maniscalco, Giorgia Teresa; Scavone, Cristina; Mascolo, Annamaria; Manzo, Valentino; Prestipino, Elio; Guglielmi, Gaspare; Aiezza, Maria Luisa; Cozzolino, Santolo; Bracco, Adele; Moreggia, Ornella; Di Giulio Cesare, Daniele; Ziello, Antonio Rosario; Falco, Angela; Massa, Marida; Majolo, Massimo; Raiola, Eliana; Soprano, Roberto; Russo, Giuseppe; Longo, Giuseppe; Andreone, Vincenzo; Capuano, Annalisa |